NASDAQ
Enzo Biochem, Inc. (ENZB) has a free cash flow growth of -72.04% as of Friday, May 29, 2026. This represents a 39.62% increase compared to its 12-month average of -119.31%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.